Glenn is a 40-year global life sciences veteran, and is CEO / founder of investment and advisory firm Red Bluff Capital. He was a former CEO / COO of Ausbiotech for 13 years and has been a senior executive in multinational and Australian life sciences companies, delivering his expertise in general management, sales, marketing, finance, distribution and manufacturing. He holds several board positions including at Horizon 3 Biotech Fund, Captix Biotechnology and Endexone.
Glenn Cross
